Patella Fracture : A Randomized Controlled Trial

Sponsor
Unity Health Toronto (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03445819
Collaborator
(none)
84
3
2
62
28
0.5

Study Details

Study Description

Brief Summary

This is a multi-centre, randomized controlled trial comparing operative and non operative treatment for displaced patella fractures in elderly, low-demand patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Group A: Surgical Treatment
  • Other: Group B: Conservative Treatment
N/A

Detailed Description

Patients with a displaced patellar fracture who meet the inclusion criteria and provide consent will be randomized to one of the two treatment arms. One group (Group A) will receive standardized non-operative treatment with immediate weight-bearing as tolerated in a knee immobilizer and early ROM exercises begun at 2 weeks post injury. The other group (Group B) will receive ORIF of their displaced patellar fracture with a standardized post-operative protocol.

Post-operative rehabilitation will be standardized across both groups. Patients will be weight bearing as tolerated immediately in a removable knee immobilizer, with progressive range-of-motion exercises begun at two weeks following surgery or randomization. The knee immobilizer will be used full-time (with the exception of removal for physiotherapy and bathing) for 6 weeks after surgery or randomization. At six weeks post-treatment, patients will be allowed to perform active extension and will initiate progressive strengthening exercises of the extensor mechanism.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Data analysts will be blinded to the study treatment.Wherever possible, outcome assessors will be blinded to the study treatment.
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Trial of Non-operative Versus Operative Management of Patella Fractures in the Elderly
Actual Study Start Date :
Nov 1, 2018
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Group A: Surgical Treatment

Open reduction and internal fixation (ORIF) of the patellar fracture will be performed using screws, wires, pins, or plate fixation at the discretion of the treating surgeon. The trial is designed in a pragmatic fashion to allow participating surgeons from the multiple participating sites to perform fixation as per the standard of care at their institution. Post-operative care will include standard-of-care antibiotics and deep vein thrombosis (DVT) prophylaxis, both prescribed at the discretion of the attending surgeon.

Procedure: Group A: Surgical Treatment
Open reduction and internal fixation (ORIF) of the patellar fracture will be performed using screws, wires, pins, or plate fixation at the discretion of the treating surgeon

Other: Group B: Conservative Treatment

Patients randomized to non-operative treatment will receive identical treatment to the operative group, minus the surgery. Patients will be weight bearing as tolerated immediately in a removable knee immobilizer, with progressive range-of-motion exercises begun at two weeks following randomization

Other: Group B: Conservative Treatment
Patients randomized to non-operative treatment will receive identical treatment to the operative group, minus the surgery.

Outcome Measures

Primary Outcome Measures

  1. Knee injury and Osteoarthritis Outcome Score (KOOS) [1 year after injury]

    A self-administered questionnaire that assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Secondary Outcome Measures

  1. Visual Analogue Pain Scale (VAS) [1 year after injury]

    VAS consists of a straight line with the endpoints defining extreme limits of pain, ranging from 'no pain at all' (zero) to 'pain as bad as it could be' (10)

  2. Range of Motion [up to 24 months]

    Measurement of flexion and extension

Other Outcome Measures

  1. TUG Test [up to 24 months]

    Timed Up and Go test

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female patients 65 years of age or older and ambulatory prior to injury (with or without walking aids).

  • Closed fracture of the patella displaced by 5 mm or greater (Displacement will be determined by measuring the widest displacement on any x-ray view with the knee in full extension).

  • The patient scores between 3 and 6 on the Clinical Frailty Scale. This score corresponds to a low-demand patient who is ambulatory and functionally independent

  • Within 14 days of injury, the patient is able to perform a straight leg raise with less than 30 degrees of extensor lag.

  • Able to read and understand the study consent form document.

  • Willing and able to sign consent, follow the study protocol and attend follow-up visits.

Exclusion Criteria:
  • Associated extremity injuries or polytrauma injuries that would otherwise require surgery or interfere substantially with rehabilitation or outcome in the opinion of the investigator.

  • Neurovascular injuries at the level of the knee requiring surgery.

  • Pathologic fractures.

  • Periprosthetic fractures, or other knee surgery which would contra-indicate inclusion in the study (e.g. previous patella ORIF or previous surgery involving patella such as patella tendon or quads repair).

  • Medical contra-indication to surgery.

  • Likely problems, in the judgment of the investigators, with maintaining follow-up (e.g. patients with no fixed address, intellectually challenged patients without adequate support, etc.).

Contacts and Locations

Locations

Site City State Country Postal Code
1 London Health Sciences Centre London Ontario Canada
2 St. Michael's Hospital Toronto Ontario Canada
3 Sunnybrook Health Sciences Centre Toronto Ontario Canada

Sponsors and Collaborators

  • Unity Health Toronto

Investigators

  • Principal Investigator: Aaron Nauth, MD, FRCS (C), Unity Health Toronto
  • Principal Investigator: Jeremy Hall, MD, FRCS(C), Unity Health Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Unity Health Toronto
ClinicalTrials.gov Identifier:
NCT03445819
Other Study ID Numbers:
  • Patella RCT 2018
First Posted:
Feb 26, 2018
Last Update Posted:
Jun 18, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Unity Health Toronto
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2021